PT83036B - Processo para a preparacao de hidroxi- e alcoxi-pirimidinas - Google Patents
Processo para a preparacao de hidroxi- e alcoxi-pirimidinasInfo
- Publication number
- PT83036B PT83036B PT83036A PT8303686A PT83036B PT 83036 B PT83036 B PT 83036B PT 83036 A PT83036 A PT 83036A PT 8303686 A PT8303686 A PT 8303686A PT 83036 B PT83036 B PT 83036B
- Authority
- PT
- Portugal
- Prior art keywords
- alcoxy
- pyrimidines
- hydroxy
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/758,199 US4711888A (en) | 1985-07-24 | 1985-07-24 | Hydroxy and alkoxy pyrimidines |
Publications (2)
Publication Number | Publication Date |
---|---|
PT83036A PT83036A (en) | 1986-08-01 |
PT83036B true PT83036B (pt) | 1989-01-30 |
Family
ID=25050889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT83036A PT83036B (pt) | 1985-07-24 | 1986-07-22 | Processo para a preparacao de hidroxi- e alcoxi-pirimidinas |
Country Status (25)
Country | Link |
---|---|
US (1) | US4711888A (pt) |
EP (1) | EP0210044B1 (pt) |
JP (1) | JPH0647579B2 (pt) |
KR (1) | KR890001549B1 (pt) |
CN (1) | CN1006792B (pt) |
AU (1) | AU569194B2 (pt) |
CA (1) | CA1265519A (pt) |
DD (1) | DD248588A5 (pt) |
DE (1) | DE3673718D1 (pt) |
DK (1) | DK162986C (pt) |
EG (1) | EG18181A (pt) |
ES (1) | ES2000734A6 (pt) |
FI (1) | FI89911C (pt) |
GR (1) | GR861917B (pt) |
HU (1) | HU196764B (pt) |
IE (1) | IE63404B1 (pt) |
IL (1) | IL79471A0 (pt) |
NO (1) | NO173442C (pt) |
NZ (1) | NZ216951A (pt) |
PH (1) | PH22484A (pt) |
PL (2) | PL150617B1 (pt) |
PT (1) | PT83036B (pt) |
SU (1) | SU1574171A3 (pt) |
YU (1) | YU45020B (pt) |
ZA (1) | ZA865489B (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2087056T3 (es) * | 1986-01-13 | 1996-07-16 | American Cyanamid Co | 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. |
US4959365A (en) * | 1986-10-31 | 1990-09-25 | Pfizer Inc. | Topical compositions of lipophilic pharmaceuticals agents |
HU199683B (en) * | 1987-07-22 | 1990-03-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity |
WO1989005295A1 (en) * | 1987-12-02 | 1989-06-15 | Pfizer Inc. | Acyl derivatives of hydroxypyrimidines |
ATE96321T1 (de) * | 1988-12-14 | 1993-11-15 | Pfizer | Derivate von 5-hydroxy- und 5-methoxy-2-aminopyrimidin als inhibitoren der interleukin-1produktion. |
US5071852A (en) * | 1988-12-14 | 1991-12-10 | Pfizer Inc. | Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production |
US4940712A (en) * | 1989-05-26 | 1990-07-10 | Pfizer Inc. | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors |
US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5356898A (en) * | 1991-01-31 | 1994-10-18 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines |
US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
US6087500A (en) * | 1996-05-16 | 2000-07-11 | Nissan Chemical Industries, Ltd. | Methods for producing pyrimidine compounds |
US5958934A (en) * | 1996-05-23 | 1999-09-28 | Syntex (U.S.A.) Inc. | Aryl pyrimidine derivatives and uses thereof |
TW440563B (en) * | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
US5952331A (en) * | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
US6489344B1 (en) | 1998-06-19 | 2002-12-03 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
AU2001280445A1 (en) | 2000-06-23 | 2002-01-08 | Vanderbilt University | Novel chain-breaking antioxidants |
DE102004054080A1 (de) * | 2004-11-09 | 2006-05-11 | Wella Ag | Haut- oder Haarbehandlungsmittel mit Schutzeffekt |
US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
JP2008156048A (ja) * | 2006-12-22 | 2008-07-10 | Isamu Nakamura | 車両用板材キャリア |
US8877766B2 (en) | 2013-02-15 | 2014-11-04 | Peter F. Kador | Neuroprotective multifunctional antioxidants and their monofunctional analogs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN153791B (pt) * | 1979-03-10 | 1984-08-18 | Soc D Etudes Prod Chimique | |
US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
EP0164204A1 (en) * | 1984-05-12 | 1985-12-11 | FISONS plc | Novel pharmaceutically useful pyrimidines |
-
1985
- 1985-07-24 US US06/758,199 patent/US4711888A/en not_active Expired - Lifetime
-
1986
- 1986-07-16 DE DE8686305466T patent/DE3673718D1/de not_active Expired - Fee Related
- 1986-07-16 EP EP86305466A patent/EP0210044B1/en not_active Expired - Lifetime
- 1986-07-21 IL IL79471A patent/IL79471A0/xx not_active IP Right Cessation
- 1986-07-22 PT PT83036A patent/PT83036B/pt not_active IP Right Cessation
- 1986-07-22 CA CA000514336A patent/CA1265519A/en not_active Expired - Fee Related
- 1986-07-22 GR GR861917A patent/GR861917B/el unknown
- 1986-07-22 EG EG453/86A patent/EG18181A/xx active
- 1986-07-23 CN CN86104539A patent/CN1006792B/zh not_active Expired
- 1986-07-23 DD DD86292804A patent/DD248588A5/de not_active IP Right Cessation
- 1986-07-23 KR KR1019860005974A patent/KR890001549B1/ko not_active IP Right Cessation
- 1986-07-23 PH PH34054A patent/PH22484A/en unknown
- 1986-07-23 ZA ZA865489A patent/ZA865489B/xx unknown
- 1986-07-23 ES ES8600529A patent/ES2000734A6/es not_active Expired
- 1986-07-23 HU HU863000A patent/HU196764B/hu not_active IP Right Cessation
- 1986-07-23 IE IE195286A patent/IE63404B1/en not_active IP Right Cessation
- 1986-07-23 FI FI863029A patent/FI89911C/fi not_active IP Right Cessation
- 1986-07-23 YU YU1321/86A patent/YU45020B/xx unknown
- 1986-07-23 DK DK349486A patent/DK162986C/da active
- 1986-07-23 NO NO862956A patent/NO173442C/no unknown
- 1986-07-23 NZ NZ216951A patent/NZ216951A/xx unknown
- 1986-07-23 SU SU864027808A patent/SU1574171A3/ru active
- 1986-07-23 AU AU60447/86A patent/AU569194B2/en not_active Ceased
- 1986-07-24 JP JP61174704A patent/JPH0647579B2/ja not_active Expired - Lifetime
- 1986-07-24 PL PL1986260784A patent/PL150617B1/pl unknown
- 1986-07-24 PL PL1986271856A patent/PL151571B1/pl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT83179B (pt) | Processo para a preparacao de carbinois aril-piperidinicos | |
PT83036B (pt) | Processo para a preparacao de hidroxi- e alcoxi-pirimidinas | |
PT81859B (pt) | Processo para a preparacao de derivados de tiazolidinodionas | |
PT83085B (pt) | Processo para a preparacao de eteres de fenilo | |
BR8802484A (pt) | Processo para a preparacao de isocianatos | |
PT83152B (pt) | Processo para a preparacao de compostos di-t-butilfenoicos | |
PT82989B (pt) | Processo para a preparacao de antibioticos beta-lactamicos | |
PT82062B (pt) | Processo para a preparacao de compostos piridinilimidazolidinona | |
BR8601962A (pt) | Processo para a preparacao de compostos | |
PT82568B (pt) | Processo para a preparacao de tintas anti-vegetativas | |
PT82917B (pt) | Processo para a preparacao de enzimas modificados | |
PT83344A (pt) | Processo para a preparacao de ypsilon-carbolinas antipsicoticas | |
PT83180B (pt) | Processo para a preparacao de esteres aril-piperidinicos | |
PT82678B (pt) | Processo para a preparacao de compostos de cinolina | |
PT83074B (pt) | Processo para a preparacao de produtos de solvatacao de 3-propenil-cefalosporina | |
PT82383B (pt) | Processo para a preparacao de epipodofilotoxina e compostos afins | |
BR8501588A (pt) | Processo para a preparacao de poliisocianatos | |
BR8803678A (pt) | Processo para a preparacao de polieteramidas | |
BR8502305A (pt) | Processo para a preparacao de organopol issiloxanas organofuncionais | |
BR8505989A (pt) | Processo para a preparacao de amino-4-difenilaminas | |
PT82245B (pt) | Processo para a preparacao de 2-amino-6-cloropurina | |
BR8603216A (pt) | Processo para a preparacao de compostos de 1-oxa-3-oxo-4-8-diaza-spiro-4-5 decano | |
BR8501134A (pt) | Processo para a preparacao de gliciditeres | |
PT83154B (pt) | Processo para a preparacao de quinolizino-sulfonamidas | |
BR8602094A (pt) | Processo para a preparacao de benzotiazolsulfenamidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19960131 |